Study of Yoga vs. Health Education for Chronic Pain in Persons Receiving Opioid Agonist Therapy
NCT03022890 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2019-08-09
Summary
The Specific Aims of this treatment development research are:
To conduct a pilot randomized clinical trial (n = 40) of hatha yoga vs. a health education group (attention control) for persons with chronic pain who are taking methadone maintenance therapy (MMT) or bupreonorphine (BUP) for opioid use disorder maintenance treatment. Participants will be enrolled in the active intervention for 3 months, and then be followed for 6 months afterwards. Investigators' aims are:
1. To assess feasibility and acceptability of both the yoga class and the health education control group. Investigators will assess credibility of the assigned intervention and expectancy for improvement for both groups at baseline, program satisfaction following program participation, participant adherence (class attendance rate and amount of home practice corresponding to assigned study arm), and instructor fidelity to the manuals. Investigators will conduct structured interviews following program participation to understand specific aspects of both programs considered attractive, useful, or not useful; we will solicit suggestions for improvements as well.
2. To assess safety, investigators will track all adverse events in a structured fashion. Investigators do not expect to see any serious adverse events definitely or probably related to study participation.
3. To assess feasibility of research procedures, investigators have benchmarks for recruitment rate, retention for study assessments, and reliability of instructor fidelity measures.
Conditions
- Opioid-Related Disorders
- Pain, Chronic
Interventions
- BEHAVIORAL
-
hatha yoga
12 weeks of hour-long gentle hatha yoga classes
- BEHAVIORAL
-
health education
12 weeks of hour-long classes on nutrition, sleep, coping with pain, and other health educaiton topics
Sponsors & Collaborators
-
National Center for Complementary and Integrative Health (NCCIH)
collaborator NIH -
Butler Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-04-01
- Primary Completion
- 2018-11-16
- Completion
- 2019-07-01
Countries
- United States
Study Locations
More Related Trials
-
Mindfulness Oriented Recovery Enhancement for Chronic Pain and Opioid Relapse
NCT04491968 ·Status: COMPLETED ·Phase: NA
-
Tailoring a Mindful Intervention to Enhance Opioid Treatment
NCT04879238 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Preliminary Efficacy of an Opioid Stewardship Program in Hospitalized Patients With Chronic Pain
NCT05370326 ·Status: COMPLETED ·Phase: NA
-
An Adaptive Walking Intervention to Manage Chronic Pain in Veterans With Opioid Use Disorder Engaged in Opioid Agonist Treatment
NCT05051644 ·Status: COMPLETED ·Phase: PHASE1
-
Mindfulness-Oriented Recovery Enhancement For Chronic Pain and Prescription Opioid Misuse in Primary Care
NCT02602535 ·Status: COMPLETED ·Phase: NA
-
Mindfulness Oriented Recovery Enhancement in Hospitalized People With Opioid Use Disorder
NCT05066321 ·Status: TERMINATED ·Phase: NA
-
Treating Opioid Misuse Via Mindfulness-Based Just-in-Time Adaptive Intervention
NCT04567043 ·Status: UNKNOWN ·Phase: NA
-
Evaluating The Efficacy Of A Mind-Body Intervention In Overcoming Opioid Addiction
NCT03791645 ·Status: COMPLETED ·Phase: NA
-
Cognitive-Behavioral Therapy for Pain and Opioid Dependence in Methadone Maintenance Treatment
NCT01334580 ·Status: COMPLETED ·Phase: PHASE1
-
Mindfulness-Based Relapse Prevention for Methadone Maintenance
NCT03882125 ·Status: COMPLETED ·Phase: NA
-
Mindful Body Awareness With Medication Treatment for Opioid Use Disorder
NCT04082637 ·Status: COMPLETED ·Phase: NA
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
NCT06032559 ·Status: RECRUITING ·Phase: PHASE3
-
CoMBAT Opioid Use Disorder: A Combined Medication and Behavioral Activation Treatment for People Living With Opioid Use Disorder
NCT04240093 ·Status: COMPLETED ·Phase: NA
-
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings
NCT01752998 ·Status: COMPLETED ·Phase: NA
-
Medication Adherence Therapy for Opioid Abusing Pain Patients
NCT00249587 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Motivational Interviewing and Guided Opioid Tapering Support to Promote Postoperative Opioid Cessation
NCT03659734 ·Status: COMPLETED ·Phase: NA
-
Advancing STOP: Self-regulation Therapy for Opioid Addiction and Pain
NCT03363243 ·Status: COMPLETED ·Phase: NA
-
Linking Opioid Dependent Patients From Inpatient Detoxification to Primary Care
NCT01751789 ·Status: COMPLETED ·Phase: NA
-
Piloting a Patient-Reported Outcome Measure for Opioid Use Disorder Recovery in a Clinical Setting
NCT05388045 ·Status: UNKNOWN ·Phase: NA
-
Application Based Addiction Treatment Adherence Trial
NCT04680741 ·Status: COMPLETED ·Phase: NA
-
Therapy for People With Opioid Use Disorder
NCT06008769 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Enhancing Exercise and Psychotherapy to Treat Pain and Addiction in Opioid Use Disorders ("EXPO" Pilot Trial)
NCT04736550 ·Status: COMPLETED ·Phase: NA
-
Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22
NCT00000240 ·Status: COMPLETED ·Phase: PHASE2
-
Opioid Treatment Program (OTP)-Pharmacy Collaboration for Methadone Maintenance Treatment
NCT04308694 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Pilot Test of a Community-based Buprenorphine Treatment Intervention
NCT01761110 ·Status: COMPLETED ·Phase: NA